/

EBS

Emergent BioSolutions Inc.Pre-market

6.98−0.08 −1.13%USD

NYSE · as of Oct 12, 16:00 ET · 20m delayPre-market 7.00 +0.29%

Open

7.08

Prev close

7.06

Day range

6.957.33

52-week range

4.3614.06

Volume

950.67K0.81×

Mkt cap

357.89M

P/E ttm

—

Fwd P/E

6.67

EPS ttm

-3.44

Div yield

0.00%

Earnings

Aug 5, 2026

From 52w high

−50.36%

Price Chart

Yahoo Finance · delayed

EBSOct 12, 2026O 7.08H 7.33L 6.95C 6.98−0.08 (−1.13%)Vol 951.00K

SMA 506.10
SMA 2008.44

1Y change −23.04% since Oct 10, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

EBS Emergent BioSolutions Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −3.59%
1 month: +12.04%
3 months: −12.86%
6 months: −15.29%
Year to date: −43.53%
1 year: −23.04%

Valuation & ownership

Market cap: 357.89M
Enterprise value: 806.39M
P/E (ttm): —
Forward P/E: 6.67
PEG ratio: 0.38
Price / book: 1.05
Price / sales (ttm): 0.46
EV / EBITDA: 3.43
EPS (ttm): -3.44
EPS (forward): 1.05
Beta (5y monthly): 2.29
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 51.27M
Float: 49.05M
Short % of float: 18.41%
Short ratio (days): 8.24
Held by insiders: 4.21%
Held by institutions: 90.55%
Avg volume (3m): 1.17M
50-day average: 6.10
200-day average: 8.44
52-week change: −23.04%
S&P 500 52-week: +17.50%

Technicals (daily)

RSI (14): 56.0
vs 50-day SMA: +14.48%
vs 200-day SMA: −17.27%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 5.76%
Realised vol (20d, ann.): 68.2%
From 52-week high: −50.36%
From 52-week low: +60.09%

ANR

Analyst Consensus

2 analysts

Consensus

—

Mean target

11.00

+57.59% implied

Low 10.00Median 11.00High 12.00

Recommendation trend

Now2 / 0 / 1
1m ago2 / 0 / 1

Buy / hold / sell counts

DES

About Emergent BioSolutions Inc.

Yahoo Finance profile

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma antitoxin for the treatment of symptomatic botulism; BioThrax, an anthrax vaccine; CYFENDUS, a vaccine for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; Ebanga, a monoclonal antibody for the treatment of infection caused by Orthoebolavirus zairense; Raxibacumab injection, a monoclonal antibody therapeutic for the treatment and prophylaxis of inhalational anthrax due to Bacillus anthracis; TEMBEXA, an oral antiviral for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; and CNJ-016, a polyclonal antibody therapeutic to address complications from smallpox vaccination. It also provides NARCAN and KLOXXADO nasal sprays for the emergency treatment of known or suspected opioid overdose. In addition, the company offers contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, analytical development, and suite reservation services. Emergent BioSolutions Inc. was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 900
Headquarters: Gaithersburg, MD, United States
Website: emergentbiosolutions.com

SEAS

Seasonality · EBS

2007–2026 · monthly returns

Strongest month May +11.10%Weakest month Apr −3.55%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-8.3	-28.1	1.8	-0.8	10.8	-8.1	-13.8	-15.5	8.2	5.8			−43.5%
2025	17.7	-33.5	-35.0	9.9	18.4	0.9	-7.8	41.2	6.3	41.5	-10.5	10.7	+29.3%
2024	-30.4	93.4	-21.7	-25.7	203.2	19.6	86.4	-34.6	0.5	8.5	11.7	-5.5	+298.3%
2023	11.7	-6.1	-16.3	-14.8	-3.4	-13.8	-6.4	-31.8	-27.5	-38.5	2.4	12.1	−79.7%
2022	7.7	-11.6	-0.8	-21.1	1.8	-5.8	11.6	-30.7	-12.6	-0.6	-41.0	-4.0	−72.8%
2021	19.3	-10.2	-3.2	-34.4	-0.5	3.9	4.6	-4.3	-20.6	-4.8	-7.4	-1.5	−51.5%
2020	2.1	6.5	-1.4	27.8	12.9	-5.3	40.7	2.5	-9.4	-12.9	-8.9	9.4	+66.1%
2019	5.2	-6.5	-13.4	2.3	-22.8	21.0	-8.6	-0.8	19.4	9.3	-4.0	-1.7	−9.0%
2018	5.0	1.9	5.9	-1.5	-0.6	-2.1	7.6	14.1	6.2	-7.0	19.0	-18.6	+27.6%
2017	-7.8	3.7	-7.5	3.0	6.8	6.2	7.3	2.6	8.4	1.3	7.2	5.8	+41.5%
2016	-8.5	-7.6	7.4	6.0	13.9	-35.9	18.7	-20.2	18.3	-15.3	0.1	22.7	−17.9%
2015	2.9	6.9	-4.0	3.2	7.3	3.4	-0.4	1.4	-14.4	12.8	17.2	6.2	+46.9%
2014	4.1	3.4	2.1	4.3	-17.7	3.6	-2.0	13.2	-14.4	6.1	9.9	9.5	+18.4%
2013	0.1	-3.5	-9.7	9.7	-7.4	1.5	22.7	-0.6	8.4	2.5	15.0	2.4	+43.3%
2012	0.8	-10.0	4.8	-12.1	2.6	5.1	-3.6	0.8	-3.5	-6.5	13.0	6.8	−4.8%
2011	-9.5	-0.9	14.8	-3.6	7.3	-9.7	-8.4	-12.5	-14.6	22.2	-9.7	-1.2	−28.2%
2010	5.4	2.4	14.5	-3.0	-3.3	3.7	13.6	-2.2	-5.0	4.7	1.4	28.1	+72.6%
2009	-16.0	-11.9	-30.0	-20.7	2.1	31.0	0.2	29.0	-4.7	-18.3	-0.4	-5.4	−48.0%
2008	47.4	0.1	19.4	5.5	14.2	-7.6	35.6	2.9	-5.6	37.6	25.6	15.4	+416.0%
2007	35.2	-16.7	6.8	-2.1	-23.8	2.9	-9.8	-3.9	-0.6	13.5	-44.5	-9.5	−54.7%

INSD

Insider Activity · EBS

Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

1.08M shares

Sells, 6 months

85.7K shares

Net shares

+997.5K

Net change in insider shares

+85.90%

Date	Insider	Transaction	Shares	Value
Oct 6, 2026	Degolyer Donald WDirector	Sale at price 7.09 per share.	17.8K	$126.20K
Sep 30, 2026	Williams Paul AnthonyOfficer	Sale at price 6.53 per share.	3K	$19.59K
Jun 30, 2026	Williams Paul AnthonyOfficer	Sale at price 8.40 per share.	3K	$25.20K
Apr 30, 2026	Degolyer Donald WDirector	Sale at price 8.36 - 8.96 per share.	15.5K	$129.99K
Apr 30, 2026	Zoon Kathryn C.Director	Sale at price 8.36 - 8.97 per share.	17.2K	$144.45K
Apr 30, 2026	Dayal Sujata TyagiDirector	Sale at price 8.36 - 8.94 per share.	13.8K	$115.61K
Apr 29, 2026	Fowler Neal FranklinDirector	Stock Award(Grant) at price 0.00 per share.	25.3K	—
Apr 29, 2026	Degolyer Donald WDirector	Stock Award(Grant) at price 0.00 per share.	25.3K	—
Apr 29, 2026	Zoon Kathryn C.Director	Stock Award(Grant) at price 0.00 per share.	25.3K	—
Apr 29, 2026	Katkin Keith ADirector	Stock Award(Grant) at price 0.00 per share.	25.3K	—
Apr 29, 2026	Dayal Sujata TyagiDirector	Stock Award(Grant) at price 0.00 per share.	25.3K	—
Apr 29, 2026	Harsanyi ZsoltChairman of the Board	Stock Award(Grant) at price 0.00 per share.	25.3K	—
Apr 29, 2026	White Marvin LDirector	Stock Award(Grant) at price 0.00 per share.	25.3K	—
Apr 29, 2026	Richard Ronald BDirector	Stock Award(Grant) at price 0.00 per share.	25.3K	—
Apr 29, 2026	Fowler John D JrDirector	Stock Award(Grant) at price 0.00 per share.	25.3K	—
Apr 29, 2026	Katkin Keith ADirector	Sale at price 8.28 per share.	15.5K	$128.18K
Apr 28, 2026	Hartzel WilliamOfficer	Stock Award(Grant) at price 0.00 per share.	100.1K	—
Apr 28, 2026	Perl JessicaGeneral Counsel	Stock Award(Grant) at price 0.00 per share.	104.3K	—
Apr 28, 2026	Lowry Simon COfficer	Stock Award(Grant) at price 0.00 per share.	100.1K	—
Apr 28, 2026	Glessner ColeenOfficer	Stock Award(Grant) at price 0.00 per share.	100.1K	—

CONG

Congress Trades · EBS

House reports since 2025

Members

0 last bought

Buys

~$0

Sells

~$8.0K

Net

−$8.0K

est. bought − sold

Latest

Dec 11, 24

Steve Cohen

Members who traded it

Member	Buys	Sells	Est. net	Last move
Steve Cohen TN09		1	−$8.0K	Sold Dec 11, 24

Bought and sold by quarter (est.)

House members' EBS trades, newest first
Traded	Member	Owner	Type	Amount	Filed	Report
Dec 11, 24	Steve Cohen TN09	Self	Sell	$1,001 - $15,000	Jan 10, 25 (30d)	PDF

From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades

EBS

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

EBS

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Emergent BioSolutions Inc.

Seasonality · EBS

Insider Activity · EBS

Congress Trades · EBS

Members who traded it

Bought and sold by quarter (est.)

Congress Trades · EBS

Members who traded it

Bought and sold by quarter (est.)

Insider Activity · EBS

Seasonality · EBS

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Emergent BioSolutions Inc.

Financial Snapshot

Earnings & Dividends

News